Woman wins $4 million in Prempro breast cancer trial 
By:
Sylvia Hsieh
Published: April 27, 2012
Tags: breast cancer, drug litigation, hormone replacement therapy, HRT litigation, Pfizer, Prempro, Wyeth
A 65-year-old elementary school principal has won a $4 million verdict in Connecticut federal court against the maker of the menopause drug Prempro for causing her breast cancer.
Prempro plaintiff can’t show causation, District Court rules
Published: March 13, 2012
Tags: breast cancer, causation, failure to warn, hormone replacement therapy, Premarin, Prempro, product liability, Provera, Upjohn, Wyeth
A product liability plaintiff could not show that the alleged failure of pharmaceutical companies to warn about the dangers of their hormone therapy drugs was the proximate cause of her breast cancer, a U.S. District Court in South Carolina has ruled in granting summary judgment.
HRT drug claim isn’t barred by prior bankruptcy
Published: February 24, 2012
Tags: cancer, hormone replacement therapy litigation, Prempro, product liability, Wyeth
A product liability lawsuit against drug maker Wyeth was not barred by the plaintiff’s failure to declare her claim as an asset in her bankruptcy case prior to obtaining a discharge of debts, a U.S. District Court in Mississippi has ruled in denying summary judgment.
Pa. court reinstates $28M punitive award in HRT case
Published: January 10, 2012
Tags: breast cancer, HRT litigation, Premarin, Prempro, product liability, Provera, Upjohn, Wyeth
A $28 million award of punitive damages was not unconstitutionally excessive in a product liability case brought by a woman who contracted breast cancer after taking hormone replacement therapy drugs, a Pennsylvania appellate court has ruled in reversing judgment.
Wyeth’s marketing efforts admissible in Prempro case
Published: January 10, 2012
Tags: breast cancer, HRT litigation, Prempro, product liability, Wyeth
Evidence of Wyeth’s marketing campaign for “off-label” Prempro uses was admissible in a product liability case brought by a woman who contracted breast cancer after taking the drug, a Pennsylvania appellate court has ruled.
Wyeth accused of using sham patents to stop generic Effexor
Published: July 13, 2011
Tags: antitrust, Effexor XR, generic drugs, patent litigation, Pfizer, Wyeth
An antitrust lawsuit filed in federal court in Mississippi alleges that Wyeth Pharmaceuticals used fraudulently obtained patents as part of a scheme to delay the introduction of generic versions of the anti-depressant Effexor XR.
Prempro verdict, punitive award reinstated on appeal
Published: June 15, 2011
Tags: Prempro, product liability, Wyeth
A jury’s $1.6 million verdict for the plaintiff in a Prempro case should be reinstated along with a sealed punitive award against drugmaker Wyeth, a Pennsylvania appellate court has ruled.
Small firm turns the tide on Prempro litigation
By:
Sylvia Hsieh
Published: January 18, 2011
Tags: breast cancer, hormone replacement therapy, hormone replacement therapy litigation, HRT litigation, Prempro, Wyeth, Wyeth Pharmaceuticals
In the ongoing mass tort over the hormone replacement therapy drug Prempro, two small firms recently teamed up to break the defense winning streak in the trials.
Drug litigation in review 2010
By:
Tony Ogden
Published: January 4, 2011
Tags: Accutane, Allergan, antidepressant, Avandia, AztraZeneca, Botox, Botox litigation, Department of Justice, DOJ, epilepsy, failure to warn, GlaxoSmithKline, heart attack, hormone replacement therapy, hormone replacement therapy litigation, Johnson & Johnson, Levaquin, Neurontin, Paxil, Pfizer, Premarin, Prempro, Provera, Roche, Seroquel, Wyeth
Much like 2009, 2010 was a busy year for prescription drug suits.
Hormone drug plaintiffs must show reliance
By:
Pat Murphy
Published: January 3, 2011
Tags: consumer protection, deceptive trade practices, hormone replacement therapy, product liability, reliance, Wyeth
Consumers must show detrimental reliance in order to hold a drug manufacturer liable for misleading statements in its marketing of hormone replacement therapy drugs, West Virginia’s highest court has ruled.
NEW FREE WHITE PAPER: E-Discovery
This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.
Click here to get your free White Paper today!
